Features of nephropathy prevention in patients with type 2 diabetes mellitus

Due to the high prevalence of diabetes mellitus, there is an annual increase in the number of patients with diabetic nephropathy. And the complications of the progressive course of this high percentage of development of end-stage renal failure require clear approaches to early diagnosis, development of methods of prevention and timely treatment of the medical position. This review provides evidence-based recommendations for glucose-lowering therapy, control of arterial and proteinuria, hyperlipidemia, hyperglycemia depending on the level of albuminuria excretion and the severity of glucose-lowering drugs depending on the level of glomerular filtration rate. Individual goals for patient correction are determined. Specific application possibilities are indicated. The article emphasizes that glycemic control is a key factor in preventing the development of DN and the worsening of existing symptoms. Diabetic nephropathy is the most common cause of chronic renal failure in chronic kidney disease (CKD), requiring hemodialysis, accounting for more than 50% of all new cases of CKD.